ACE and hepatocellular carcinoma: In conclusion, our results demonstrate that DTA-expressing plasmid inhibited proliferation of HCC cells and DTA expression in an AFP-promoter-dependent manner and reduced the growth of HCC in vivo and decreased the tumor markers of AFP and DCP.